Publication | Closed Access

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Mucosal VaccinationImmunologyPathologyTherapeutic VaccineColorectal Cancer PatientsLiposomal EmulsionImmunotherapyMedicineViral OncologyRecombinant Baculovirus-derived KsaTumor Microenvironment